27-hydroxycholesterol has been researched along with Bone Loss, Osteoclastic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdo, J; DuSell, CD; Gesty-Palmer, D; Javitt, NB; Khosla, S; McDonnell, DP; Mödder, UI; Nelson, ER; Umetani, M; Wang, X | 1 |
DuSell, CD; Evans, G; Gesty-Palmer, D; Howe, MK; Khosla, S; McDonnell, DP; Michalek, RD; Nelson, ER; Rathmell, JC; Umetani, M; Wang, X | 1 |
2 other study(ies) available for 27-hydroxycholesterol and Bone Loss, Osteoclastic
Article | Year |
---|---|
The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis.
Topics: Animals; Bone and Bones; Bone Density; Bone Resorption; Cholestanetriol 26-Monooxygenase; Cytochrome P450 Family 7; Estradiol; Female; Homeostasis; Hydroxycholesterols; Mice; Mice, Knockout; Osteoblasts; Osteogenesis; Selective Estrogen Receptor Modulators; Steroid Hydroxylases | 2010 |
The oxysterol, 27-hydroxycholesterol, links cholesterol metabolism to bone homeostasis through its actions on the estrogen and liver X receptors.
Topics: Animals; Bone and Bones; Bone Resorption; Cell Differentiation; Cholesterol; Homeostasis; Hydroxycholesterols; Liver X Receptors; Mice; Orphan Nuclear Receptors; Osteoblasts; Receptors, Estrogen; Receptors, Steroid; Sterols | 2011 |